Abstract
Assessment of Genetic Variability in an Inflammatory Bowel Disease Patients Population by a Clinical Exome Survey
Dago Dougba Noel*, Koffi N’Guessan Bénédicte Sonia, Yao Saraka Dider Martial, Giacomelli Mauro, Marinella Pinelli and Raffaele Badolato
Corresponding Author: Dago Dougba Noel, Department of Genetic and Biochemistry, Genetic Research Unit, Peleforo Gon Coulibaly University of Korhogo, Ivory Coast.
Accepted: August 26, 2021 Available Online: August 30, 2021
Citation: Noel DD, Sonia KNB, Martial YSD, Mauro G, Pinelli M, et al. (2021) Assessment of Genetic Variability in an Inflammatory Bowel Disease Patients Population by a Clinical Exome Survey. Proteomics Bioinformatics, 3(S1):1.
Copyrights: ©2021 Noel DD, Sonia KNB, Martial YSD, Mauro G, Pinelli M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share :
  • 695

    Views & Citations
Inflammatory bowel disease (IBDs) is complex, multifactorial disorder that comprise Crohn’s disease (CD) and ulcerative colitis (UC). Recent discoveries have brought much attention to the genetic predisposition of patients with IBD. Considering that IBDs are genetics and multi-factorial diseases, we embarked here in assessing genetic diversity in four (4) IBDs pediatric patients (patient 1, 2, 3 and 4) previously submitted to a clinical exome sequencing. Genomic sequences obtained from that analysis were aligned on hg19 human genome by bowtie2 package in Galaxy platform. Next, we performed variant features calling (VCF) analysis. Focusing on genetic variants covered by at least 20 reads, we selected and quantified genomic functions due to exonic and intronic mutations in each IBDs patients. Multivariate statistical analysis as well as analysis of variance (ANOVA) from R package, applied to that quantitative data do not support any variance difference between IBD patients (p>0.05). The same surveys, by applying “fitcon” parameter (fitcon ≥0.6 for mutation in exon and 0.3≤ fitcon ≤0.4 for mutation in intron), indicating the probability that a given mutation significantly impacts the phenotype, attributed genetic variability in the IBD population to intronic mutations (p=0.20), contrary to exonics mutations (p=0.97). Pair-wise statistical test applying the same fitcon parameters confirmed intron mutations as favoring genetic variability. The same statistical test shown a relative difference between IBD patient 2 and IBD patients 1 (p=0.24), 3 (p=0.31) and 4 (p=0.34) respectively, confirming Crohn’s phenotype of the latter by contrast to IBD patient 2 ulcerative colitis phenotypes. Our survey suggested the integration between biostatistics and next generation sequencing, as a valid support in characterizing genetic diversity in an IBD population.

Keywords: Inflammatory bowel disease, Crohn disease, Exome sequencing, Biostatistics